Ifp Advisors, Inc Organogenesis Holdings Inc. Transaction History

Ifp Advisors, Inc

$2.91 Billion
Q4 2024

A detailed history of Ifp Advisors, Inc transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 9 shares of ORGO stock, worth $28. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$28

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 04, 2025	BUY	$2.77 - $4.43 $24 - $39	9 New	9 $0
Q4 2022 Feb 07, 2023	BUY	$2.48 - $3.43 $372 - $514	150 New	150 $1,000

Others Institutions Holding ORGO

# of Institutions

124

Shares Held

62M

Call Options Held

4.3K

Put Options Held

3.9K

Soleus Capital Management, L.P. Greenwich, CT

12.5M
Shares

$40.1 Million
2.78% of portfolio
Morgan Stanley New York, NY

11.8M
Shares

$38 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$16.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.59M
Shares

$11.5 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.08M
Shares

$9.9 Million
0.03% of portfolio

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $420M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account